Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3588)
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,147
Price
$67.20
Total Value
$480.27K
Shares Held After
528,539
% of Holdings
1.3%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
735,462
Price
$0.06
Total Value
$45.60K
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
24,946
Price
$0.40
Total Value
$9.98K
Shares Held After
437,758
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
98
Price
$550.53
Total Value
$53.95K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$549.77
Total Value
$660.83K
Shares Held After
40,611
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,289
Price
$548.81
Total Value
$707.42K
Shares Held After
41,813
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,366
Price
$547.85
Total Value
$1.30M
Shares Held After
43,102
% of Holdings
5.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,808
Price
$546.88
Total Value
$1.54M
Shares Held After
45,468
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,737
Price
$545.99
Total Value
$948.38K
Shares Held After
48,276
% of Holdings
3.5%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
2,064
Price
$64.14
Total Value
$132.38K
Shares Held After
1,785,242
% of Holdings
0.1%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
15,401
Price
$6.40
Total Value
$98.57K
Shares Held After
700,000
% of Holdings
2.2%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,858
Price
$103.78
Total Value
$192.82K
Shares Held After
60,486
% of Holdings
3.0%
Equillium, Inc. (EQ)
Connelly Stephen — President and CSO
Shares
30,975
Price
$2.94
Total Value
$91.07K
Shares Held After
762,025
% of Holdings
3.9%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
14,584
Price
$2.93
Total Value
$42.74K
Shares Held After
62,586
% of Holdings
18.9%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
23,588
Price
$3.58
Total Value
$84.46K
Shares Held After
2,175,796
% of Holdings
1.1%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.62
Total Value
$144.80K
Shares Held After
883,735
% of Holdings
4.3%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,064
Price
$4.42
Total Value
$9.12K
Shares Held After
173,224
% of Holdings
1.2%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
618
Price
$1.57
Total Value
$970.26
Shares Held After
64,508
% of Holdings
1.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
6,125
Price
$1.57
Total Value
$9.62K
Shares Held After
638,960
% of Holdings
1.0%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
39,741
Price
$17.49
Total Value
$695.07K
Shares Held After
250,934
% of Holdings
13.7%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
11,000
Price
$18.00
Total Value
$198.00K
Shares Held After
416,775
% of Holdings
2.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
450
Price
$68.27
Total Value
$30.72K
Shares Held After
4,338,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
15,921
Price
$67.74
Total Value
$1.08M
Shares Held After
4,338,897
% of Holdings
0.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,429
Price
$66.72
Total Value
$95.35K
Shares Held After
4,354,818
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
2,200
Price
$65.72
Total Value
$144.58K
Shares Held After
4,356,247
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
450
Price
$68.27
Total Value
$30.72K
Shares Held After
535,686
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
15,921
Price
$67.74
Total Value
$1.08M
Shares Held After
536,136
% of Holdings
2.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,429
Price
$66.72
Total Value
$95.35K
Shares Held After
552,057
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
2,200
Price
$65.72
Total Value
$144.58K
Shares Held After
553,486
% of Holdings
0.4%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
843,622
Price
$0.08
Total Value
$64.12K
Shares Held After
505,302
% of Holdings
167.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
20,072
Price
$0.44
Total Value
$8.83K
Shares Held After
462,704
% of Holdings
4.2%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
12,610
Price
$64.42
Total Value
$812.34K
Shares Held After
798,335
% of Holdings
1.6%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
68,265
Price
$63.83
Total Value
$4.36M
Shares Held After
810,945
% of Holdings
7.8%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
19,125
Price
$62.62
Total Value
$1.20M
Shares Held After
879,210
% of Holdings
2.1%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
88,487
Price
$64.28
Total Value
$5.69M
Shares Held After
716,311
% of Holdings
11.0%
Liquidia Corp (LQDA)
Manning Paul B — Director
Shares
11,513
Price
$63.13
Total Value
$726.82K
Shares Held After
804,798
% of Holdings
1.4%
Keros Therapeutics, Inc. (KROS)
Farzan Nima — Director
Shares
2,625
Price
$10.73
Total Value
$28.17K
Shares Held After
9,767
% of Holdings
21.2%
Moderna, Inc. (MRNA)
Klinger Shannon Thyme — Chief Legal Officer
Shares
3,471
Price
$50.00
Total Value
$173.55K
Shares Held After
67,468
% of Holdings
4.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
1,420
Price
$66.08
Total Value
$93.83K
Shares Held After
1,787,306
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
35,208
Price
$65.58
Total Value
$2.31M
Shares Held After
1,788,726
% of Holdings
1.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
46,108
Price
$64.47
Total Value
$2.97M
Shares Held After
1,823,934
% of Holdings
2.5%
Keros Therapeutics, Inc. (KROS)
Knowles Julius — Director
Shares
2,625
Price
$10.73
Total Value
$28.17K
Shares Held After
10,958
% of Holdings
19.3%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
19,575
Price
$6.13
Total Value
$119.99K
Shares Held After
700,000
% of Holdings
2.7%
INCYTE CORP (INCY)
Tray Thomas — Principal Accounting Officer
Shares
2,639
Price
$100.00
Total Value
$263.90K
Shares Held After
21,132
% of Holdings
11.1%
Pharvaris N.V. (PHVS)
Nijdam Anna — Principal Accounting Officer
Shares
2,670
Price
$30.87
Total Value
$82.43K
Shares Held After
46,275
% of Holdings
5.5%
Keros Therapeutics, Inc. (KROS)
Seth Alpna — Director
Shares
2,625
Price
$10.72
Total Value
$28.14K
Shares Held After
9,767
% of Holdings
21.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
40
Price
$312.23
Total Value
$12.49K
Shares Held After
1,450,253
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
964
Price
$311.36
Total Value
$300.15K
Shares Held After
1,450,293
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,652
Price
$310.43
Total Value
$823.26K
Shares Held After
1,451,257
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,784
Price
$309.49
Total Value
$861.62K
Shares Held After
1,453,909
% of Holdings
0.2%
Showing 501–550 of 3588 transactions (page 11 of 72)